{
    "2019-02-27": [
        [
            {
                "time": "2018-04-16",
                "original_text": "Trump ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, he refused",
                "features": {
                    "keywords": [
                        "Cohen",
                        "Novartis",
                        "lobby"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-07",
                "original_text": "Ophthotech's (OPHT) Q4 Loss Wider, Gene Therapy in Focus",
                "features": {
                    "keywords": [
                        "Ophthotech",
                        "Q4",
                        "Loss",
                        "Gene Therapy"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-16",
                "original_text": "Trump's ex-lawyer Cohen: drugmaker Novartis wanted him to lobby, but he declined",
                "features": {
                    "keywords": [
                        "Cohen",
                        "Novartis",
                        "lobby",
                        "declined"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-19",
                "original_text": "A Look at Sparkâ€™s Potential Revenue Contribution to Roche Holdings",
                "features": {
                    "keywords": [
                        "Spark",
                        "Revenue",
                        "Roche",
                        "Holdings"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Blackstone Life Sciences, Novartis to Launch Cardiovascular Drug Company",
                "features": {
                    "keywords": [
                        "Blackstone",
                        "Life Sciences",
                        "Novartis",
                        "Cardiovascular",
                        "Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Blackstone Life Sciences and Novartis to Launch Cardiovascular Drug Company",
                "features": {
                    "keywords": [
                        "Blackstone",
                        "Life Sciences",
                        "Novartis",
                        "Cardiovascular",
                        "Drug"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-01",
                "original_text": "Akcea Therapeutics, Inc. (AKCA) Q4 2018 Earnings Conference Call Transcript",
                "features": {
                    "keywords": [
                        "Akcea",
                        "Therapeutics",
                        "Q4",
                        "Earnings",
                        "Conference Call"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}